2023
DOI: 10.1016/j.jinf.2022.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Deficiency of HTR4 and ADRB1 caused by SARS-CoV-2 spike may partially explain multiple COVID-19 related syndromes including depression, cognitive impairment, loss of appetite, heart failure, and hypertension

et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Altered expression of genes include CX3CR1 [666], S100A12 [667], CSF2 [668], MPO (myeloperoxidase) [669], CD5L [670], F11 [671], S100A8 [672], PGLYRP1 [673], VEGFD (vascular endothelial growth factor D) [674], CXCL11 [373], BPI (bactericidal permeability increasing protein) [675], CXCL10 [676], S100A9 [677], CXCR1 [678], CXCR2 [679], ABCA3 [680], CD36 [681], SHH (sonic hedgehog signaling molecule) [682], TLR3 [683], CLEC4D [684], CCR2 [685], NEK7 [686], TLR7 [687], CCRL2 [688] and CAV1 [689] accelerates pneumonia progression. CX3CR1 [666], CD177 [690], PF4 [691], FFAR2 [692], MPO (myeloperoxidase) [693], F11 [694], S100A8 [695], VEGFD (vascular endothelial growth factor D) [674], IL1A [696], BPI (bactericidal permeability increasing protein) [697], AQP4 [698], BDNF (brain derived neurotrophic factor) [699], CXCL10 [700], RNASE2 [701], FCGR3B [702], S100A9 [703], IL1B [704], CXCR2 [705], GPIHBP1 [294], CD36 [706], TRIB3 [707], PCSK9 [708], FGF2 [709], FASN (fatty acid synthase) [710], PNPLA3 [711], HSPA6 [712], VIP (vasoactive intestinal peptide) [713], TLR3 [683], ADRB1 [328], SPOCK2 [714], TLR8 [715], CCR2 [716], IFIT3 [717], NEK7 [718], TLR7 [687], EFNB2 [719], CAV1 [720], CR1 [721] and AQP5 [722] plays essential roles in viral respiratory diseases. Previous study confirmed that CX3CR1 [723], S100A12 [724], CD177 [725], PF4 [726], MPO (myeloperoxidase) [727], CD5L [728], F11 […”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Altered expression of genes include CX3CR1 [666], S100A12 [667], CSF2 [668], MPO (myeloperoxidase) [669], CD5L [670], F11 [671], S100A8 [672], PGLYRP1 [673], VEGFD (vascular endothelial growth factor D) [674], CXCL11 [373], BPI (bactericidal permeability increasing protein) [675], CXCL10 [676], S100A9 [677], CXCR1 [678], CXCR2 [679], ABCA3 [680], CD36 [681], SHH (sonic hedgehog signaling molecule) [682], TLR3 [683], CLEC4D [684], CCR2 [685], NEK7 [686], TLR7 [687], CCRL2 [688] and CAV1 [689] accelerates pneumonia progression. CX3CR1 [666], CD177 [690], PF4 [691], FFAR2 [692], MPO (myeloperoxidase) [693], F11 [694], S100A8 [695], VEGFD (vascular endothelial growth factor D) [674], IL1A [696], BPI (bactericidal permeability increasing protein) [697], AQP4 [698], BDNF (brain derived neurotrophic factor) [699], CXCL10 [700], RNASE2 [701], FCGR3B [702], S100A9 [703], IL1B [704], CXCR2 [705], GPIHBP1 [294], CD36 [706], TRIB3 [707], PCSK9 [708], FGF2 [709], FASN (fatty acid synthase) [710], PNPLA3 [711], HSPA6 [712], VIP (vasoactive intestinal peptide) [713], TLR3 [683], ADRB1 [328], SPOCK2 [714], TLR8 [715], CCR2 [716], IFIT3 [717], NEK7 [718], TLR7 [687], EFNB2 [719], CAV1 [720], CR1 [721] and AQP5 [722] plays essential roles in viral respiratory diseases. Previous study confirmed that CX3CR1 [723], S100A12 [724], CD177 [725], PF4 [726], MPO (myeloperoxidase) [727], CD5L [728], F11 […”
Section: Discussionmentioning
confidence: 99%
“…By performing DEGs analysis, 479 up regulated and 479 down regulated DEGs were successfully identified (|logFC| > 0.512 for up regulated genes, |logFC| < -0.831 for down regulated genes and adjust P-value < .05), respectively. Involvement of SLCO1A2 molecule) [315], DACH1 [316], PNPLA3 [317], FGF9 [192], SLC7A11 [193], SGPP1 [318], VIP (vasoactive intestinal peptide) [319], KCNJ2 [320], KL (klotho) [321], SMAD6 [135], BMPR2 [322], APOA1 [323], CALCRL (calcitonin receptor like receptor) [324], INSIG1 [325], RASGRF1 [198], LRRK2 [326], TLR3 [327], ADRB1 [328], SLC22A3 [329], CA2 [330], SNX10 [331], LIFR (LIF receptor subunit alpha) [332], TLR8 [333], CMPK2 [334], GATA3 [335], RSPO2 [336], CCR2 [205], NEK7 [337], TLR7 [338], BEX1 [339], EFNB2 [340], CAV1 [341], ARRB1 [342], TRPC3 [343], CR1 [344], PEG10 [345], DLL4 [346], MEFV (MEFV innate immuity regulator, pyrin) [347], TFPI (tissue factor pathway inhibitor) [348], EPAS1 [349], FADS1 [215], DKK2 [350], CACNA2D2 [351], DPP6 [352]…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the endocytic recycling of angiotensin converting enzyme 2 (ACE2), glucose transporter type 1 (GLUT1), hydroxytryptamine receptor 4 (HTR4) and adrenoceptor beta 1 (ADRB1) was inhibited by SARS-CoV-2 S, possibly explaining some COVID symptoms associated with deficiency of those surface proteins. (Ren et al, 2022a;Ren et al, 2022b;Lv et al, 2023) The underlying mechanisms are that the spike (S) protein from SARS-CoV-2 binds to SNX27's PDZ domain and reduces the association between SNX27 and Vps26A. (Ren et al, 2022a;Ren et al, 2022b) Since ATP7A is also a cargo of SNX27 in the recycling pathway, (Steinberg et al, 2013) SARS-CoV-2 S protein may suppress ATP7A recycling to the cell surface by associating with SNX27.…”
Section: Conclusion and Prospectmentioning
confidence: 99%